FREE TRIAL
Highly specialized industry insight on the Asian marketplace, plus editor’s picks from the world press and English summaries of Chinese and Japanese news
About
|
Staff
|
Subscribe/Renew
|
Advertise
PharmAsiaNews provides exclusive regulatory, reimbursement and business intelligence for the biopharma and medical devices industries - direct from editorial bureaus in China, India, Japan, Korea, Australia and the Pacific Rim.
China, India and other nations in the Pacific Rim have emerged as key players in the global biomedical industry. Understanding the issues - regulatory compliance, reimbursement, IP commercial strategy, business development, outsourcing, R&D, clinical trials, manufacturing - is essential. The editorial team of PharmAsiaNews has access to a comprehensive network of insiders in industry, government and the investment community - so you can get exclusive analysis and insight you can't find elsewhere.
Our local market coverage and insights include:
- Daily analysis of critical developments from editors based on the ground in Asia
- Guest columns by industry experts on regulatory, legal and business strategies for Asia
- Editor's picks of the most important Asian biomedical news written elsewhere on the Web
- English-language summaries of news about your company and competitors from the Chinese and Japanese press
- Newsfeeds of the latest Asian press releases and wire-service stories collected 24/7
Your PharmAsiaNews free trial will include:
- Around-the-clock coverage of the rapidly expanding Asian marketplace
- Email newsletter: Delivered five days a week to your inbox
- RSS feed: Get the latest news and analysis instantly via RSS feed